Research progress on the role of lncRNAs in the occurrence and development of glaucoma
10.3760/cma.j.cn115989-20220221-00068
- VernacularTitle:LncRNAs对青光眼发生和发展的作用研究进展
- Author:
Ruijuan GUAN
1
;
Xin YAN
;
Zefeng KANG
Author Information
1. 西宁市第一人民医院眼科，西宁 810000
- Publication Type:Journal Article
- Keywords:
RNA, long noncoding;
Apoptosis;
Retinal ganglion cells;
Research progress
- From:
Chinese Journal of Experimental Ophthalmology
2025;43(5):466-470
- CountryChina
- Language:Chinese
-
Abstract:
Glaucoma refers to a group of heterogeneous eye diseases, which is characterized by the gradual loss of visual field caused by the progressive deepening of the optic disc, optic nerve atrophy and slow apoptosis of retinal ganglion cells and their axons, ultimately leading to blindness.The vision loss caused by glaucoma is irreversible and it is a heavy burden on families and society.Therefore, the importance of early diagnosis and prevention should be emphasized.Genetic factors play an important role in the pathogenesis of glaucoma.In recent years, studies have found that long non-coding RNAs (lncRNAs) affect the occurrence and development of glaucoma by regulating the expression of glaucoma-related genes.For example, lncRNA ANRIL, lncRNA MALAT1, lncRNA GAS5 and lncRNA TUG1 can regulate the expression of related genes, and affect the survival of retinal ganglion cells by interfering with intraocular pressure, cell apoptosis, oxidative stress and other mechanisms.LncRNA ANRIL and LncRNA TGF-β2AS1 can regulate the expression of related genes in trabecular meshwork cells and affect the biological function of trabecular meshwork cells.LncRNA MEG3 and lncRNA FAM22B can regulate the expression of scar formation related genes and intervene in the process of filter passage scar formation after filtration.This article summarizes and comments on the characteristics of lncRNAs and the regulation mechanism of gene expression related to the occurrence and development of glaucoma, so as to provide new information for the prevention and treatment of glaucoma.
